| 1 |
34739844 | Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL. | 2021 Dec 13 |
1 |
| 2 |
30901302 | Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma. | 2019 May 20 |
3 |
| 3 |
29724297 | Ibrutinib improves the development of acute lymphoblastic leukemia by activating endoplasmic reticulum stress-induced cell death. | 2018 May 1 |
1 |
| 4 |
24625454 | Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era. | 2014 Nov |
1 |
| 5 |
25042202 | Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study. | 2014 Aug |
2 |